Maplight Therapeutics, Inc. · NASDAQ:MPLT
Lillie James Woodruff sold 11,513 Maplight Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Lillie James Woodruff (Chief Scientific Officer) sold 11,513 Maplight Therapeutics, Inc. shares at US$8.08 for US$93,025, leaving 198,597 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 11,513 shares
- Price
- US$8.08
- Value
- US$93,025
- Holding after
- 198,597 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Voting Common Stock | Sale | 11,513 | US$8.08 | 198,597 | Direct |
Source
Download original · View original at SEC
Related
- Maplight Therapeutics, Inc.
- Lillie James Woodruff
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Lillie James Woodruff · Aug 19, 2026
- Form 4 · Lillie James Woodruff · Aug 4, 2026
- Form 4 · Lillie James Woodruff · Jul 17, 2026
- Form 4 · Lillie James Woodruff · May 11, 2026
- Form 4 · Lillie James Woodruff · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026